![]() |
|
searchpremiumIHS CHEMICAL WEEK BUSINESS DAILY eventsfree featuresadvertisingcustomer care |
EnviroTech :: Innovation Lonza to Supply Commercial Volumes of Antibody Drug4:57 AM MST | November 10, 2009 | Alex Scott Lonza has disclosed that GlaxoSmithKline (GSK) and Genmab’s antibody drug Arzerra, for treating chronic lymphocytic leukemia (CLL), will be manufactured by Lonza. Arzerra, also known as ofatumumab, is a monoclonal antibody. The drug recently has been... This information is only available to Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|